D.W. Cescon
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 2
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Komal L. Jhaveri (2 shared papers)Aditya Bardia (2 shared papers)Barbara Pistilli (3 shared papers)Junji Tsurutani (2 shared papers)Michelino De Laurentiis (2 shared papers)Hope S. Rugo (2 shared papers)Masaya Hattori (2 shared papers)Binghe Xu (2 shared papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
D.W. Cescon
4 papers receiving 676 citations
D.W. Cescon's Hit Papers
Peers
Comparison fields: 5 of 39
- Oncology 462
- Cancer Research 251
- Immunology 44
- Pulmonary and Respiratory Medicine 46
- Biological Psychiatry 1
Countries citing papers authored by D.W. Cescon
This map shows the geographic impact of D.W. Cescon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.W. Cescon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.W. Cescon more than expected).
Fields of papers citing papers by D.W. Cescon
This network shows the impact of papers produced by D.W. Cescon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.W. Cescon. The network helps show where D.W. Cescon may publish in the future.
Co-authors
The 25 scholars most cited alongside D.W. Cescon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study Hit paper breakdown → | 2018 | 681 |
| 2 | 2024 | 7 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 1 | |
| 5 | 2026 | 1 | |
| 6 | 2026 | 0 | |
| 7 | 2026 | 0 | |
| 8 | 2026 | 0 |
About D.W. Cescon
D.W. Cescon is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 8 papers that have together received 693 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Genomics and Diagnostics (2 papers) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Oncology (462 citations), Cancer Research (251 citations), Immunology (44 citations), Pulmonary and Respiratory Medicine (46 citations) and Biological Psychiatry (1 citation). D.W. Cescon has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Komal L. Jhaveri, Aditya Bardia, Barbara Pistilli, Junji Tsurutani, Michelino De Laurentiis, Hope S. Rugo, Masaya Hattori, Binghe Xu, Kevin M. Kalinsky and Seock‐Ah Im. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.